Vivo Capital, LLC
CIK 1674712 · View on SEC EDGAR ↗
- Portfolio value
- $1.1B
- Positions
- 47
- As of
- June 30, 2026
#2,308 of 9,443 by 13F value · top 24.4%
Portfolio value QoQ: -9.0% 13F does not disclose cash
- Top 10 holdings weight
- 52.40%
- Top 25 holdings weight
- 87.77%
- Positions above 1%
- 28
- Effective number of positions
- 24.4
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 13.55% Est. buys $155,716,945 · sells $353,838,199
Median holding: 4.0 quarters Tracked Q4 2024–Q2 2026 · 60.3% still held
- New positions
- 7
- Increased
- 6
- Decreased
- 8
- Closed
- 6
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Sector breakdown
Healthcare
98.4%
Other/Unmapped
1.6%
Full portfolio 47 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| TRVI Trevi Therapeutics, Inc. - Common Stock | $95,015,558 | 8.68% | 5,094,668 | $34,236,169 | |||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $90,766,926 | 8.29% | 271,116 | $-18,421,654 | Down ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $75,614,188 | 6.90% | 4,127,412 | $-120,996,758 | Down ×1 | ||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $58,436,050 | 5.34% | 1,682,097 | $37,997,968 | Up ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $55,289,441 | 5.05% | 414,899 | $28,616,773 | Up ×1 | ||
| TNGX Tango Therapeutics, Inc. - Common Stock | $43,131,579 | 3.94% | 1,379,769 | $-1,946,419 | Down ×1 | ||
| CRVS Corvus Pharmaceuticals, Inc. - Common Stock | $41,918,891 | 3.83% | 2,805,816 | $869,803 | |||
| DRUG Bright Minds Biosciences Inc. - common stock | $39,113,474 | 3.57% | 557,172 | $-1,543,367 | |||
| SVA Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) | $38,192,410 | 3.49% | 5,903,000 | $0 | |||
| TENX Tenax Therapeutics, Inc. - Common Stock | $36,375,000 | 3.32% | 2,500,000 | $33,043,755 | Up ×1 | ||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $35,414,630 | 3.23% | 6,694,637 | $10,414,632 | Up ×1 | ||
| DYN Dyne Therapeutics, Inc. - Common Stock | $34,591,320 | 3.16% | 1,557,466 | $6,354,461 | |||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $34,507,725 | 3.15% | 353,998 | $4,800,213 | |||
| ANRO Alto Neuroscience, Inc. Common Stock | $31,901,763 | 2.91% | 1,208,858 | $8,622,577 | Up ×1 | ||
| DBVT DBV Technologies S.A. - American Depositary Shares | $30,254,031 | 2.76% | 1,844,758 | $-25,471,485 | Down ×1 | ||
| SABS SAB Biotherapeutics, Inc. - Common Stock | $28,469,645 | 2.60% | 7,299,909 | $-15,268,955 | Down ×1 | ||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $27,258,000 | 2.49% | 1,400,000 | $8,618,000 | Up ×1 | ||
| LBRX LB Pharmaceuticals Inc - Common Stock | $25,964,000 | 2.37% | 800,000 | $6,236,000 | |||
| NERV Minerva Neurosciences, Inc - Common Stock | $23,991,246 | 2.19% | 4,322,747 | $-2,053,305 | |||
| DSGN Design Therapeutics, Inc. - Common Stock | $23,338,706 | 2.13% | 1,612,903 | $6,177,418 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $20,022,352 | 1.83% | 1,848,786 | $-3,401,767 | |||
| CAMP CAMP4 Therapeutics Corporation - Common Stock | $18,557,502 | 1.69% | 4,246,568 | $-169,863 | |||
| SNSE Sensei Biotherapeutics, Inc. - Common Stock | $18,050,500 | 1.65% | 722,020 | $-4,707,570 | |||
| ACHV Achieve Life Sciences, Inc. - Common Shares | $17,964,239 | 1.64% | 2,751,032 | Up ×1 | |||
| CMPX Compass Therapeutics, Inc. - Common Stock | $16,987,961 | 1.55% | 7,757,060 | $-33,507,554 | Down ×1 | ||
| ANTX AN2 Therapeutics, Inc. - Common Stock | $15,263,618 | 1.39% | 3,153,640 | $4,478,169 | |||
| EDIT Editas Medicine, Inc. - Common Stock | $11,519,010 | 1.05% | 3,555,250 | Up ×1 | |||
| GERN Geron Corporation - Common Stock | $11,099,900 | 1.01% | 8,671,797 | $-1,821,078 | |||
| Unknown issuer (CUSIP: 67613T104) | $10,758,250 | 0.98% | 575,000 | Up ×1 | |||
| EPRX Eupraxia Pharmaceuticals Inc. - Common Stock | $8,923,500 | 0.81% | 1,350,000 | $-850,500 | |||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $8,790,358 | 0.80% | 1,927,710 | $809,639 | |||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $8,404,756 | 0.77% | 671,843 | $-1,612,423 | |||
| MNPR Monopar Therapeutics Inc. - Common Stock | $8,379,395 | 0.77% | 90,500 | $3,420,900 | |||
| AURA Aura Biosciences, Inc. - Common Stock | $8,283,336 | 0.76% | 1,166,667 | Up ×1 | |||
| SRZN Surrozen, Inc. - Common Stock | $6,747,000 | 0.62% | 260,000 | $-826,800 | |||
| ALXO ALX Oncology Holdings Inc. - Common Stock | $6,592,356 | 0.60% | 3,184,713 | $207,006 | |||
| MSLE Satellos Bioscience Inc. - Common Stock | $6,326,253 | 0.58% | 813,666 | $1,745,313 | |||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $5,082,000 | 0.46% | 275,000 | Up ×1 | |||
| PEPG PepGen Inc. - Common Stock | $4,185,000 | 0.38% | 2,325,000 | $69,750 | |||
| VALN Valneva SE - American Depositary Shares | $3,991,531 | 0.36% | 763,199 | Up ×1 | |||
| SERA Sera Prognostics, Inc. - Class A Common Stock | $3,003,801 | 0.27% | 1,650,440 | $-346,592 | |||
| UNCY Unicycive Therapeutics, Inc. - Common Stock | $2,579,500 | 0.24% | 550,000 | $-9,198,147 | Down ×1 | ||
| TIL Instil Bio, Inc. - Common Stock | $2,251,194 | 0.21% | 292,743 | $-161,008 | |||
| INM InMed Pharmaceuticals Inc. - Common Shares | $1,237,484 | 0.11% | 798,377 | Up ×1 | |||
| BOLT Bolt Biotherapeutics, Inc. - Common Stock | $278,794 | 0.03% | 72,414 | $-13,759 | |||
| KTTA Pasithea Therapeutics Corp. - Common Stock | $239,904 | 0.02% | 465,471 | $-1,317,876 | Down ×1 | ||
| DTIL Precision BioSciences, Inc. - Common Stock | $36,746 | 0.00% | 4,675 | $11,033 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| ERAS | Trimmed | -8.0M | -$121.0M |
| AVBP | Bought more | +796K | +$38.0M |
| TRVI | Price move only | +0 | +$34.2M |
| CMPX | Trimmed | -1.8M | -$33.5M |
| ABVX | Bought more | +175K | +$28.6M |
| DBVT | Trimmed | -823K | -$25.5M |
| PRAX | Trimmed | -68K | -$18.4M |
| SABS | Trimmed | -4.1M | -$15.3M |
| ACRS | Bought more | +28K | +$10.4M |
| UNCY | Trimmed | -1.2M | -$9.2M |
1 position hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| CDTX | March 31, 2026 | 956,670 | $211,318,836 | No longer tracked |
| VRNA | Dec. 31, 2025 | 1,393,432 | $148,693,129 | No longer tracked |
| TERN | June 30, 2026 | 1,334,418 | $70,350,517 | No longer tracked |
| AVDL | March 31, 2026 | 2,684,109 | $57,842,549 | No longer tracked |
| ZBIO | March 31, 2026 | 853,495 | $30,990,403 | 63.2% |
| TRML | Dec. 31, 2025 | 591,882 | $28,309,716 | No longer tracked |
| AKRO | Dec. 31, 2025 | 434,689 | $20,639,034 | No longer tracked |
| RZLT | Dec. 31, 2025 | 2,112,432 | $19,856,861 | 107.8% |
| MANE | June 30, 2026 | 300,000 | $18,945,000 | -14.8% |
| COGT | June 30, 2026 | 422,300 | $16,254,327 | -6.6% |
| CTMX | March 31, 2026 | 2,884,615 | $12,288,460 | -28.1% |
| ATXS | Dec. 31, 2025 | 1,552,685 | $11,303,547 | No longer tracked |
| SLNO | June 30, 2026 | 294,909 | $9,873,553 | No longer tracked |
| ABEO | March 31, 2026 | 1,842,751 | $9,711,298 | 36.4% |
| CMPS | Sept. 30, 2025 | 3,362,385 | $9,414,678 | 140.9% |
| IOBT | Sept. 30, 2025 | 6,173,439 | $8,581,080 | No longer tracked |
| VSTM | March 31, 2026 | 1,106,524 | $8,542,365 | 31.1% |
| CELC | Sept. 30, 2025 | 610,500 | $8,150,175 | 86.6% |
| SLN | March 31, 2026 | 1,105,454 | $6,721,160 | 151.6% |
| DCTH | Dec. 31, 2025 | 569,526 | $6,122,405 | 65.2% |
| ETNB | Dec. 31, 2025 | 376,804 | $5,539,019 | No longer tracked |
| PALI | March 31, 2026 | 2,293,578 | $5,389,908 | 19.7% |
| RGLS | June 30, 2025 | 2,696,426 | $4,718,746 | No longer tracked |
| VRDN | June 30, 2026 | 166,288 | $3,252,593 | 34.0% |
| CRBP | March 31, 2025 | 166,794 | $1,968,169 | 88.7% |
| CMPS | June 30, 2026 | 200,000 | $1,106,000 | -2.4% |
| ENGNW | March 31, 2026 | 285,046 | $843,736 | -88.8% |
| ALLK | June 30, 2025 | 765,500 | $174,228 | No longer tracked |
| DBVT | March 31, 2025 | 32,020 | $98,942 | 112.9% |
| ALGS | June 30, 2025 | 10,199 | $84,142 | -8.2% |
| QTTB | March 31, 2025 | 20,559 | $70,723 | 880.0% |